tiprankstipranks
Advertisement
Advertisement

HK:1952 Stock Latest News

Everest Medicines Details PSVT Asset Purchase and Readies for China Launch
Company AnnouncementsEverest Medicines Details PSVT Asset Purchase and Readies for China Launch
1d ago
1952
Everest Medicines to Buy Asia-Pacific Chronic Disease Portfolio in US$250 Million Deal
PremiumCompany Announcements
Everest Medicines to Buy Asia-Pacific Chronic Disease Portfolio in US$250 Million Deal
21d ago
1952
Everest Medicines Honorary Chairman Boosts Stake in Company
PremiumCompany Announcements
Everest Medicines Honorary Chairman Boosts Stake in Company
30d ago
1952
Everest Medicines Publishes Audited 2025 Annual Results and Report
PremiumCompany Announcements
Everest Medicines Publishes Audited 2025 Annual Results and Report
1M ago
1952
Everest Medicines to Acquire Cardiovascular Drug Assets in Up to US$50 Million Deal
PremiumCompany Announcements
Everest Medicines to Acquire Cardiovascular Drug Assets in Up to US$50 Million Deal
1M ago
1952
Everest Medicines Pays RMB200 Million Deposit for Potential Asia-Pacific Chronic Disease Portfolio Acquisition
PremiumCompany AnnouncementsEverest Medicines Pays RMB200 Million Deposit for Potential Asia-Pacific Chronic Disease Portfolio Acquisition
1M ago
1952
Everest Medicines Sets March 2026 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Everest Medicines Sets March 2026 Board Meeting to Approve 2025 Annual Results
2M ago
1952
Everest Medicines Shareholders Approve Commercial Pact and New 2026 Equity Incentive Scheme
Premium
Company Announcements
Everest Medicines Shareholders Approve Commercial Pact and New 2026 Equity Incentive Scheme
2M ago
1952
Everest Medicines Wins China Approval for Ulcerative Colitis Drug VELSIPITY and Outlines Ambitious 2030 Growth Plan
PremiumCompany Announcements
Everest Medicines Wins China Approval for Ulcerative Colitis Drug VELSIPITY and Outlines Ambitious 2030 Growth Plan
3M ago
1952
Everest Medicines Secures Exclusive Asian Rights to First-in-Class SHPT Drug MT1013
PremiumCompany Announcements
Everest Medicines Secures Exclusive Asian Rights to First-in-Class SHPT Drug MT1013
3M ago
1952
Everest Medicines Calls Virtual EGM to Approve Commercial Deal and New Share Incentive Plan
PremiumCompany Announcements
Everest Medicines Calls Virtual EGM to Approve Commercial Deal and New Share Incentive Plan
3M ago
1952
Everest Medicines Sets February 2026 Date and Book Closure for Extraordinary General Meeting
PremiumCompany Announcements
Everest Medicines Sets February 2026 Date and Book Closure for Extraordinary General Meeting
3M ago
1952
Everest Medicines Signs Connected Lease for Expanded Shanghai R&D and Production Site
PremiumCompany AnnouncementsEverest Medicines Signs Connected Lease for Expanded Shanghai R&D and Production Site
3M ago
1952
Everest Medicines Delays Shareholder Circular on Commercialization Service Agreement
Premium
Company Announcements
Everest Medicines Delays Shareholder Circular on Commercialization Service Agreement
3M ago
1952
Everest Medicines Chairman Boosts Stake With HK$1.14 Million Share Purchase
Premium
Company Announcements
Everest Medicines Chairman Boosts Stake With HK$1.14 Million Share Purchase
4M ago
1952
Everest Medicines Warns on NEFECON Patent as Generic Wins China Approval
PremiumCompany Announcements
Everest Medicines Warns on NEFECON Patent as Generic Wins China Approval
4M ago
1952
Everest Medicines Directors and Major Shareholder Increase Stake, Signaling Confidence
PremiumCompany Announcements
Everest Medicines Directors and Major Shareholder Increase Stake, Signaling Confidence
4M ago
1952
Everest Medicines Announces Strategic Commercialization Agreement in China
PremiumCompany Announcements
Everest Medicines Announces Strategic Commercialization Agreement in China
5M ago
1952
Everest Medicines Announces Board Composition and Committee Roles
PremiumCompany Announcements
Everest Medicines Announces Board Composition and Committee Roles
5M ago
1952
Everest Medicines Expands into Ophthalmology with VIS-101 Agreement
PremiumCompany AnnouncementsEverest Medicines Expands into Ophthalmology with VIS-101 Agreement
6M ago
1952
Everest Medicines Grants Options to Chairman to Enhance Governance
Premium
Company Announcements
Everest Medicines Grants Options to Chairman to Enhance Governance
7M ago
1952
Everest Medicines Announces Leadership Changes
Premium
Company Announcements
Everest Medicines Announces Leadership Changes
7M ago
1952

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >